Twist Bioscience: Patrick Finn
Twist Bioscience has promoted Patrick Finn to the newly created position of president and chief operating officer. Finn previously served as chief commercial officer at Twist. He joined the company in 2015 and was promoted to CCO in 2019. Prior to Twist, Finn was at Enzymatics (now part of Qiagen), where he was VP of sales, leading commercial activities for North America and Europe. Prior to Enzymatics, he held positions of increasing responsibility, including director of business development, at Agilent Technologies. Finn also previously worked for Beckman Coulter, Invitrogen, and GE Healthcare/Amersham International. He holds a PhD in nucleic acid chemistry from Southampton University and a BSc Hons in chemistry from Heriot-Watt University.